Gary C. Brown

Center for Occupational Research and Development — United States

Medicine · Health Sciences

71h-index16.6kcitations457works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(124), Retinal and Optic Conditions(105), Health Systems, Economic Evaluations, Quality of Life(93), Retinal Imaging and Analysis(78), Intraocular Surgery and Lenses(71)

Publications451 total

1118-P: Implementing a Community-Based Diabetes Screening for the Unhoused
Diabetes·2025
Educational Costs Expended and Career Incomes in Advanced Healthcare Professions.
PubMed·2024
Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology Retina·2023· 2 cited
Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost–Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration
Ophthalmology and Therapy·2023· 4 citedOpen Access
Numerical Model Based Analysis of River Training and Habitat Structures on River Processes: Straubs Bend of the Missouri River
2023Open Access
Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US
Canadian Journal of Ophthalmology·2022· 2 cited
Technical assessment of the Old, Mississippi, Atchafalaya, and Red (OMAR) Rivers : Mississippi River multi-dimensional model
2022· 3 citedOpen Access
Old River, Mississippi River, Atchafalaya River, and Red River (OMAR) system technical assessment : main report
2022· 3 citedOpen Access
Quality of life associated with no light perception vision
Canadian Journal of Ophthalmology·2022· 2 cited
Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233–235)
Ophthalmology·2022
Value-based Medicine and Gene Therapy
International Ophthalmology Clinics·2021
Vision-related quality-of-life estimates in adolescent youths
Canadian Journal of Ophthalmology·2021· 7 cited
Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis
JAMA Ophthalmology·2021· 18 citedOpen Access
A Cost-Benefit Analysis of VEGF-Inhibitor Therapy for Neovascular Age-Related Macular Degeneration in the United States
American Journal of Ophthalmology·2020· 25 cited
Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration
American Journal of Ophthalmology·2020· 31 cited
Reply to Comment on: Cost-Effectiveness of Limited Vitrectomy for Vision Degrading Myodesopsia
American Journal of Ophthalmology·2020· 1 cited
Economic Evaluation of Anti–Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
JAMA Ophthalmology·2019· 1 cited
Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).
Ophthalmology·2019
Cost-utility analysis of cataract surgery in the United States for the year 2018
Journal of Cataract & Refractive Surgery·2019· 41 cited
Ethnicity and Diabetic Quality-of-Life
The American Journal of the Medical Sciences·2019· 7 cited
page 1 of 23Next →

Frequent Co-authors

Melissa M. Brown(17), Sanjay Sharma(11), Larry E. Magargal(10), Allen C. Ho(7), Jerry A. Shields(7), William Tasman(6), James J. Augsburger(5), William E. Benson(5), Brandon Busbee(5), Carl D. Regillo(4), Arunan Sivalingam(4), Julia A. Haller(3), Peter J. Savino(3), Richard E. Goldberg(3), Jay L. Federman(3), Gaurav K. Shah(3), Heidi Brown(3), Robert C. Sergott(3), Joshua D. Stein(3), George R. Beauchamp(3)